InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Zaderej Karen L., Chairman & CEO. Director active across 2 companies, notably Axogen, Inc.. In total, 20 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €140k. Activity tracked since 19 July 2021. The latest transaction was disclosed on 11 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Zaderej Karen L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
2,000 shares0Common StockSEC:0001562180-25-005391:0
5,000 shares@ US$5.8118.5% of flowCommon StockSEC:0001562180-25-003997:0
Canonical exit: 14 Aug 2025 (T+90)
5,000 shares@ US$5.4217.3% of flowCommon StockSEC:0001562180-25-003873:0
Canonical exit: 12 Aug 2025 (T+90)
12,500 shares@ US$7.9864.2% of flowCommon StockSEC:0001562180-24-006431:0
Canonical exit: 17 Nov 2024 (T+90)
2,000 shares0Common StockSEC:0001562180-24-005698:0
84,847 shares0Common StockSEC:0000805928-24-000051:0
22,076 shares0Common StockSEC:0000805928-23-000135:0
2,000 shares0Common StockSEC:0001562180-23-005879:0
25,000 shares0Common StockSEC:0000805928-23-000028:0
4,400 shares0Common StockSEC:0000805928-22-000135:0
26,746 shares@ US$5.097.6% of flowCommon StockSEC:0000805928-22-000131:0
22,076 shares0Common StockSEC:0000805928-22-000086:0
25,950 shares0Common StockSEC:0000805928-22-000035:0
13,978 shares0Common StockSEC:0000805928-22-000015:0
4,400 shares0Common StockSEC:0000805928-21-000185:0
3,125 shares0Common StockSEC:0000805928-21-000177:0
52,375 shares@ US$8.9546.0% of flowCommon StockSEC:0000805928-21-000171:0
8,254 shares@ US$5.094.0% of flowCommon StockSEC:0000805928-21-000165:0
75,000 shares@ US$5.0935.9% of flowCommon StockSEC:0000805928-21-000163:0
22,077 shares0Common StockSEC:0000805928-21-000146:0
20 of 20 declarations
About Zaderej Karen L.
Zaderej Karen L. is President and Chief Executive Officer and has filed 20 forms in total. Across the 20 recent filings available, the period runs from 2021-07-21 to 2025-07-11, with EUR 140164 of purchases and EUR 0 of sales, and the most common transaction type is Option exercise. The filings concern Axogen, Inc. and EyePoint Pharmaceuticals, Inc.
